Medtronic MiniMed Rebrand: Diabetes Business Update
Medtronic’s diabetes business takes on the MiniMed role, a important rebrand reflecting a 40-year legacy of pioneering diabetes care.This strategic move, announced today, marks progress for the autonomous entity, aiming to simplify diabetes management. The change, honoring MiniMed’s roots, signifies a commitment to innovation, with technologies designed to streamline glucose level maintenance. The separation is expected within 18 months. The company, employing over 8,000 people, centers on making life with diabetes more predictable. For more insights, see this update via News Directory 3. Discover what’s next as MiniMed continues its progress of new technologies.
Medtronic’s Diabetes Unit to take on MiniMed Role
Updated June 14, 2025
Medtronic’s planned New Diabetes Company will operate under the name MiniMed, officials announced. The decision recognizes the company’s origins and its 40-year history of innovation in diabetes treatment. Medtronic acquired MiniMed in 2001.
The naming represents progress toward separating medtronic’s diabetes business into an independent entity.The new MiniMed seeks to ease the daily challenges of managing diabetes, developing technologies to automate glucose level maintenance.
MiniMed, based in Northridge, Calif., employs more than 8,000 people.medtronic anticipates the separation will conclude within 18 months, pending standard conditions and legal approvals. The company’s mission is to make living with diabetes more predictable.
“Our journey began in 1983, when visionary entrepreneur Alfred E. Mann founded MiniMed and revolutionized diabetes care with many first-of-its-kind innovations,” said Que Dallara, executive vice president and president of Medtronic Diabetes and chief executive officer designate of MiniMed.”we’re thrilled to honor this rich 40-year legacy with a name that carries deep meaning and trust. As we step forward into this new and exciting chapter, we’ll focus relentlessly on fulfilling our Mission.”
What’s next
MiniMed will continue developing new technologies to improve diabetes management and aims to reduce the burden on patients.